Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ)
CNY 7.84
(0.38%)
CNY 7.84
(0.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 524.5 Million | 493.7 Million | -413.68 Million | 389.31 Million | 359.14 Million | 231.79 Million |
| Net Income | 159.58 Million | 158.89 Million | 54.31 Million | 189.49 Million | 69.02 Million | 112.74 Million |
| Depreciation & Amortization | 268.86 Million | 275.4 Million | 257.49 Million | 224.11 Million | 190.88 Million | 143.27 Million |
| Deferred income taxes | - | -10.85 Million | -28.03 Million | -11.75 Million | - | - |
| Stock-based compensation | 3.61 Million | 10.85 Million | 28.03 Million | 11.75 Million | - | 2.75 Million |
| Change in working capital | -11.69 Million | -77.87 Million | -788.56 Million | -102.9 Million | 3.97 Million | -15.71 Million |
| Other non-cash items | 107.75 Million | 137.27 Million | 63.07 Million | 78.61 Million | 95.26 Million | -8.51 Million |
| Investing Cash Flow | -56.96 Million | -380.38 Million | 164.09 Million | -379.6 Million | -574.51 Million | -718.39 Million |
| Investments in PPE | -106.99 Million | -245.86 Million | -286.47 Million | -379.74 Million | -663.62 Million | -651.66 Million |
| Acquisitions | 31.88 Thousand | 3 Million | 390.77 Thousand | 2.42 Billion | 6617.60 | 237.68 Thousand |
| Investment purchases | -400 Million | -1.31 Billion | -510 Million | -2.42 Billion | -2.12 Billion | -4.13 Billion |
| Sales/Maturities of investments | 450 Million | 1.17 Billion | 959.44 Million | 22.47 Million | 20.68 Million | 38.46 Million |
| Other Investing Activities | 72.05 Million | 1.43 | 726.51 Thousand | -22.33 Million | 2.19 Billion | -105.19 Million |
| Financing Cash Flow | -755.19 Million | -367.93 Million | 630.13 Million | 246.32 Million | 698.5 Million | -219.39 Million |
| Debt repayment | -544.37 Million | -1.52 Billion | -680.82 Million | -285.1 Million | -228.26 Million | -85.86 Million |
| Dividends payments | -117.87 Million | -39.28 Million | -34.79 Million | -33.89 Million | -35.34 Million | -49.78 Million |
| Common Stock Repurchased | - | - | - | -37 Million | -64.01 Million | -145.04 Million |
| Common Stock Issuance | - | - | - | 37 Million | 64.01 Million | - |
| Other Financing Activities | -92.93 Million | 1.32 Billion | 1.45 Billion | 635.19 Million | 1 Billion | -83.74 Million |
| Accounts receivables | 20.68 Million | -35.69 Million | 2.54 Million | 53.69 Million | -15.33 Million | -7.44 Million |
| Accounts payables | -6.09 Million | 43.21 Million | 121.01 Million | -30.97 Million | 38.58 Million | 21.77 Million |
| Inventory | -26.29 Million | -85.39 Million | -912.12 Million | -125.62 Million | -19.28 Million | -30.05 Million |
| Other working capital | -6.09 Million | 0.06 | 0.82 | 0.13 | -0.33 | 14.33 Million |
| Cash at beginning of period | 1.32 Billion | 1.58 Billion | 1.2 Billion | 944.2 Million | 461.06 Million | 1.16 Billion |
| Cash at end of period | 1.03 Billion | 1.32 Billion | 1.58 Billion | 1.2 Billion | 944.2 Million | 461.06 Million |
| Capital Expenditure | -106.99 Million | -245.86 Million | -286.47 Million | -379.74 Million | -663.62 Million | -651.66 Million |
| Effect of forex changes on cash | - | 0.60 | 0.90 | 0.67 | - | - |
| Net cash flow / Change in cash | -287.65 Million | -254.61 Million | 380.55 Million | 256.03 Million | 483.13 Million | -706 Million |
| Free Cash Flow | 417.5 Million | 247.84 Million | -700.15 Million | 9.57 Million | -304.47 Million | -419.87 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 59.17 Million | -5.26 Million | 34.74 Million | -15.94 Million | 159.58 Million | -21.94 Million |
| Depreciation & Amortization | - | 69.86 Million | 69.86 Million | 68.07 Million | 268.86 Million | -132.6 Million |
| Deferred income taxes | - | - | - | - | - | 143.07 Million |
| Stock-based compensation | - | - | - | 3.61 Million | 3.61 Million | -2.71 Million |
| Change in working capital | - | 23.78 Million | - | -5.6 Million | -11.69 Million | -7.75 Million |
| Other non-cash items | 61.81 Million | 163.49 Million | 66.42 Million | 69.08 Million | 107.75 Million | 86.01 Million |
| Investing Cash Flow | -63.36 Million | -70.22 Million | -32.24 Million | 30.54 Million | -56.96 Million | -16.98 Million |
| Investments in PPE | -49.17 Million | -29.1 Million | -82.24 Million | -39.45 Million | -106.99 Million | -19.17 Million |
| Acquisitions | 904.42 Thousand | 897.31 Thousand | 1382.00 | - | 31.88 Thousand | 6898.79 |
| Investment purchases | -15.1 Million | -160.4 Million | - | -80 Million | -400 Million | -6898.69 |
| Sales/Maturities of investments | 3400.17 | 118.38 Million | 50 Million | 150 Million | 450 Million | 2.17 Million |
| Other Investing Activities | 904.42 Thousand | -33.64 Million | 51.26 Million | -1.00 | 72.05 Million | 6898.79 |
| Financing Cash Flow | 65.93 Million | -300.67 Million | 410.13 Million | -813.84 Million | -755.19 Million | -60.52 Million |
| Debt repayment | -86.01 Million | -236.44 Million | -505.35 Million | -791.52 Million | -544.37 Million | -137.24 Million |
| Dividends payments | -20.07 Million | -64.22 Million | -95.21 Million | -22.29 Million | -117.87 Million | -23.28 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -64.22 Million | -95.21 Million | -24.04 Thousand | -92.93 Million | 100 Million |
| Accounts receivables | - | 8.66 Million | - | 20.68 Million | 20.68 Million | -4.02 Million |
| Accounts payables | - | - | - | - | -6.09 Million | - |
| Inventory | - | 15.11 Million | - | -26.29 Million | -26.29 Million | -3.72 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.23 Billion | 1.55 Billion | 1.03 Billion | 1.7 Billion | 1.32 Billion | 1.71 Billion |
| Cash at end of period | 1.35 Billion | 1.24 Billion | 1.55 Billion | 1.03 Billion | 1.03 Billion | 1.7 Billion |
| Capital Expenditure | -49.17 Million | -29.1 Million | -82.24 Million | -39.45 Million | -106.99 Million | -19.17 Million |
| Effect of forex changes on cash | 9038.07 | -4906.00 | - | - | - | -2.17 Million |
| Net cash flow / Change in cash | 123.55 Million | -305.53 Million | 511.69 Million | -662.09 Million | -287.65 Million | -15.63 Million |
| Free Cash Flow | 71.8 Million | 59.26 Million | 18.92 Million | 81.75 Million | 417.5 Million | 44.89 Million |
KYE
UCG
KTY
HWH
SAKTHIFIN
CMOT